Home
                       
Contact us Home         Search   go
Company News
Purdue's 10 Point
    Program
Media Contacts

News & Announcements - OxyContin® (Oxycodone HCl Controlled-Release)Tablets Information Archives

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001


2010

2009

2008
Purdue Pharma L.P. Announces Resolution of OxyContin® Patent Lawsuit with Mallinckrodt Inc.09/02/2008
Statement of Purdue Pharma Regarding Joint Meeting of the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee05/05/2008
Statement of Purdue Pharma L.P. in Response to the Decision Confirming the Enforceability of its OxyContin Patents01/07/2008

2007
Statement of Purdue Pharma Regarding July 20 Proceedings in the United States District Court for the Western District of Virginia07/20/2007
Information on Resolution of Investigation by United States Attorney's Office, Western District of Virginia05/10/2007
Purdue Pharma L.P. Announces Agreement to End OxyContin® Patent Lawsuit with IMPAX Laboratories04/02/2007

2006
Purdue Pharma L.P. Announces Signing of Consent Judgment Ending OxyContin® Tablets Patent Lawsuit with Teva Pharmaceuticals10/16/2006
Purdue Pharma L.P. Announces Agreement to End OxyContin® Patent Lawsuit with Teva Pharmaceuticals08/29/2006
Purdue Pharma L.P. Announces Resolution of OxyContin® Patent Lawsuit with Endo Pharmaceuticals08/28/2006
Statement of Purdue Regarding Endo Patent Decision02/01/2006
Purdue Pharma L.P. and Denver Health Announce Agreement on National Surveillance System to Monitor Abuse and Diversion of Prescription Medications01/12/2006
OxyContin® Dismissals and Withdrawals Exceed 40001/05/2006

2005
FBI-LEEDA Recognizes Purdue Pharma for Innovative Contributions to Law Enforcement03/29/2005

2004
Purdue Pharma L.P. Implements Radio Frequency ID System for Drug Packaging to Deter Counterfeiting and Diversion11/15/2004
Purdue Pharma Awards Ten New Communities That Care® Grants 09/20/2004
Purdue Pharma Sponsors New Education Program To Raise Awareness Of Prescription Drug Abuse In 13,000 Middle Schools06/14/2004
Major Sweep Nets Five in Pharmacy Robbery Ring04/29/2004
Purdue Pharma L.P. Files, Serves Appeal Brief in Endo Case04/02/2004
Purdue Pharma Comments on GAO Report on OxyContin® Abuse and Diversion01/22/2004
Purdue Files Petition with FDA Requesting Risk Management Plans for All Generic Forms of OxyContin01/09/2004

2003
Purdue Pharma Sponsors Ten Communities That Care® Locations - Grants Total $250,00012/18/2003
City of Boston Announces First-of-its-Kind Educational Program to Combat Teen Prescription Drug Abuse in Boston11/03/2003
State and Community Groups Partner With Purdue Pharma to Combat Prescription Drug Abuse10/17/2003
New Public-Private Partnership To Combat Prescription Drug Abuse Among Maine Youth06/19/2003
New Partnership Will Educate SC Teens and Parents on the Dangers of Abusing Prescription Drugs06/18/2003
Kentucky Federal Judge Dismisses OxyContin® Case03/19/2003
Statement on DDMAC Warning Letter01/22/2003
Purdue Pharma Will Replace OxyContin® Tablets Stolen From Pharmacies 01/21/2003

2002
Thousands of Counterfeit OxyContin® Tablets Seized by U.S. Customs Service12/04/2002
Boston Area Residents Urged To Report Information On Pharmacy Robbers Click Here to Hear Audio10/24/2002
Purdue Pharma Implements National Surveillance System To Track Diversion And Abuse Of Controlled Pain Medications06/27/2002
Purdue Pharma Provides Update on Development of New Abuse-Resistant Pain Medications06/18/2002
Federal Judge in Kentucky Rejects Injunction on Oxycontin01/02/2002

2001
Purdue Pharma Begins Shipment of Specially Marked OxyContin Tablets to Mexico and Canada11/20/2001
International Patent Application To Be Published on Abuse-Resistant08/08/2001
 
Show Recent Only...
 


Please click here for Legal Restrictions and Terms of Use applicable to this site.
Use of this site signifies your agreement to the terms of use.
Privacy Policy
Copyright 2010 Purdue Pharma L.P.